Insider · CIK 0001802188
Blaine Davis
Files at RNAC (Cartesian Therapeutics, Inc.). First filing Jan 7, 2025, latest Jan 7, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNAC: Cartesian Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Cartesian Therapeutics, Inc. | $134k 7,989 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | RNAC Cartesian Therapeutics, Inc. | SOpen-market sale Common Stock | -3,961 | $16.72 | $66k | 98,839 | Jan 7, 2025 |
| Jan 6, 2025 | RNAC Cartesian Therapeutics, Inc. | SOpen-market sale Common Stock | -4,028 | $16.83 | $68k | 94,811 | Jan 7, 2025 |
| Jan 2, 2025 | RNAC Cartesian Therapeutics, Inc. | AGrant or award Common Stock | +22,000 | $0.00 | $0 | 102,800 | Jan 6, 2025 |
| Jan 2, 2025 | RNAC Cartesian Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +64,600 | $0.00 | $0 | 64,600 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.